Works matching IS 13518216 AND DT 2024 AND VI 30 AND IP 2
Results: 38
Issue Information.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 253, doi. 10.1111/hae.14992
- Publication type:
- Article
Arthroscopic ankle surgery in people with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 286, doi. 10.1111/hae.14967
- By:
- Publication type:
- Article
Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 419, doi. 10.1111/hae.14965
- By:
- Publication type:
- Article
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 336, doi. 10.1111/hae.14963
- By:
- Publication type:
- Article
The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 567, doi. 10.1111/hae.14962
- By:
- Publication type:
- Article
Assessment of rare bleeding disorders in adolescents with heavy menstrual bleeding.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 490, doi. 10.1111/hae.14961
- By:
- Publication type:
- Article
Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 345, doi. 10.1111/hae.14960
- By:
- Publication type:
- Article
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 545, doi. 10.1111/hae.14955
- By:
- Publication type:
- Article
Reliability and construct validity of the ACTIVLIM‐Hemo and Haemophilia Activities List (HAL) questionnaires in individuals with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 497, doi. 10.1111/hae.14954
- By:
- Publication type:
- Article
Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single‐institution cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 470, doi. 10.1111/hae.14953
- By:
- Publication type:
- Article
Morphological analysis of patellofemoral joint in haemophilic arthropathy: A case‐control study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 531, doi. 10.1111/hae.14952
- By:
- Publication type:
- Article
Bone mineral density in haemophilia patients: A systematic review and meta‐analysis.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 276, doi. 10.1111/hae.14951
- By:
- Publication type:
- Article
Adult haematology clinics for menstruating/pregnant patients: A single center experience and lessons learned: Haematology/Gynaecology Clinics for Adults.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 564, doi. 10.1111/hae.14950
- By:
- Publication type:
- Article
Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 410, doi. 10.1111/hae.14948
- By:
- Publication type:
- Article
Dentistry for patients with haemophilia: Trialling a safe and economical change in management.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 404, doi. 10.1111/hae.14947
- By:
- Publication type:
- Article
Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 355, doi. 10.1111/hae.14946
- By:
- Publication type:
- Article
The frequency of sarcopenia in haemophilia patients: Effects on musculoskeletal health and functional performance.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 505, doi. 10.1111/hae.14945
- By:
- Publication type:
- Article
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 257, doi. 10.1111/hae.14944
- By:
- Publication type:
- Article
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 437, doi. 10.1111/hae.14943
- By:
- Publication type:
- Article
Knowledge gaps in health‐related quality of life research performed in children with bleeding disorders – A scoping review.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 295, doi. 10.1111/hae.14941
- By:
- Publication type:
- Article
Non‐surgical correction of knee flexion deformity in persons with haemophilia: A staged multidisciplinary approach.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 523, doi. 10.1111/hae.14940
- By:
- Publication type:
- Article
Joint bleeds in mild hemophilia: Prevalence and clinical characteristics.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 331, doi. 10.1111/hae.14939
- By:
- Publication type:
- Article
Health‐related quality of life of Indonesian children with hemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 463, doi. 10.1111/hae.14937
- By:
- Publication type:
- Article
Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 320, doi. 10.1111/hae.14936
- By:
- Publication type:
- Article
Emicizumab and asparaginase, A first experience to share.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 561, doi. 10.1111/hae.14935
- By:
- Publication type:
- Article
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 306, doi. 10.1111/hae.14934
- By:
- Publication type:
- Article
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 395, doi. 10.1111/hae.14932
- By:
- Publication type:
- Article
Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 367, doi. 10.1111/hae.14927
- By:
- Publication type:
- Article
Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post‐marketing study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 388, doi. 10.1111/hae.14930
- By:
- Publication type:
- Article
Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single‐centre, real‐world experience of surgery
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 538, doi. 10.1111/hae.14929
- By:
- Publication type:
- Article
Patient and caregiver preferences for haemophilia treatments: A discrete‐choice experiment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 375, doi. 10.1111/hae.14928
- By:
- Publication type:
- Article
Safety of recombinant activated factor VII for treatment of breakthrough bleeds in patients with congenital haemophilia A and inhibitors receiving emicizumab prophylaxis: Review of the real‐world evidence.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 267, doi. 10.1111/hae.14933
- By:
- Publication type:
- Article
The psychosocial impact of haemophilia from patients' and caregivers' point of view: The results of an Italian survey.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 449, doi. 10.1111/hae.14926
- By:
- Publication type:
- Article
Successful hip arthroplasty in a patient with combined deficiency of factor V and factor FVIII.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 558, doi. 10.1111/hae.14925
- By:
- Publication type:
- Article
A post hoc comparative real‐world analysis of HEAD‐US score for joint health assessment of patients with severe haemophilia A and B in Spain.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 513, doi. 10.1111/hae.14924
- By:
- Publication type:
- Article
Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 478, doi. 10.1111/hae.14922
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of emicizumab prophylaxis in patients with haemophilia A in India.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 426, doi. 10.1111/hae.14921
- By:
- Publication type:
- Article
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 554, doi. 10.1111/hae.14923
- By:
- Publication type:
- Article